Schedule 13G ownership disclosure

Caribou Biosciences Inc

Common Stock · CUSIP: 142038108

Event date: 2025-03-31

Filing-level shares
4,522,032
Percent of class
4.86%
  • The Vanguard Group

    Shares: 4,522,032 · Class: 4.86%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000487
Form type
SCHEDULE 13G/A
Filer
Caribou Biosciences, Inc.
CIK
CIK 1619856
Filed
Apr 30, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub